AP
Annexin Pharmaceuticals via Annexin Incentive Stock: price and insider trades · Sweden
Annexin Pharmaceuticals via Annexin Incentive: what insiders have been doing
We have very little insider data for Annexin Pharmaceuticals via Annexin Incentive so far: the most recent filing dates from 3 May 2018. With so few records, no pattern can be drawn yet. Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
Last declaration on 3 May 2018
Declarations1 total
- 309,464 shares@ SEK 0.48100.0% of flowFI:csv-2baeaa9068b545dbd83f
1 of 1 declaration
About Annexin Pharmaceuticals via Annexin Incentive
Annexin Pharmaceuticals is a company listed on the XSTO market, focused on developing innovative treatments for inflammatory diseases and coagulation disorders. It utilizes annexin technology to create targeted therapeutic solutions.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations